Antineoplastic Agent (HER2-targeted antibody-drug conjugate)

Kadcyla Injection: Uses, Dosage, Side Effects, Precautions and Alternates

Kadcyla Injection (trastuzumab emtansine) treats HER2-positive breast cancer via IV infusion every 3 weeks. Learn uses, dosage, side effects, and warnings.